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LONG-TERM COMPUTED TOMOGRAPHY FOLLOW-UP OF SPHENOID/ 
SELLAR SKULL BASE RECONSTRUCTION AFTER TRANSSPHENOIDAL 
SURGERY. Nora E. Canty (sponsored by Craig D. Friedman). Department of 
Otolaryngology, Yale University, School of Medicine, New Haven, CT. 
The transsphenoidal surgical approach is the most common route used for 
extirpation of lesions in the anterior pituitary. In many patients, however, it 
is difficult to attain a stable closure of the sellar floor defect using the 
traditional technique of autogenous soft tissue packing and bone grafting to 
prevent cerebrospinal fluid leak. Recent studies have identified a new 
biomaterial, hydroxyapatite cement (HAC), as an efficacious implant in 
cranial defect repair and reconstruction. 
Hydroxyapatite cement has been studied prospectively to repair skull 
base defects in patients undergoing transsphenoidal surgery. This study 
reports the long term radiographic evaluation of this new method of repair of 
the cranial base defects caused during transsphenoidal surgery. 
Postoperative non-contrast computed tomography follow-up of 13 patients 
with hydroxyapatite cement implanted in the sphenoid sinus during 
transsphenoidal surgery for pituitary lesions were evaluated for stability, 
integrity, fracture, migration, and periprosthetic lucency. Two year computed 
tomography follow-up examinations revealed stability in the implant 
position, shape, and volume. There was less than a 2% change in the interface 
characteristics. It is believed that HAC will become a standard tool in the 
management of sellar floor defects post transsphenoidal surgery and in other 
non-stress bearing applications in the skull base and craniofacial skeleton. 
- * 
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INTRODUCTION 
It is estimated that there are approximately 2500 new cases of anterior 
pituitary tumors each year [6]. Pituitary adenomas are traditionally divided 
into two classes: microadenomas (<10mm) and macroadenomas (>10mm). 
They are further classified as functioning or nonfunctioning. Functioning 
adenomas secrete hormones that may cause endocrinologic symptoms, and 
are therefore most likely to be found as a microadenoma. The symptoms of 
macroadenomas tend to be related to mass effect, for example bitemporal 
hemianopsia which occurs with compression of the optic chiasm [4]. 
With the exception of endosellar prolactinomas, which are initially 
treated medically with bromocriptine, transsphenoidal hypophysectomy is the 
first fine therapy for intrasellar tumors. Transsphenoidal surgery is also 
indicated for tumors associated with cerebrospinal fluid (CSF) rhinorrhea, 
pituitary apoplexy, tumor extension into the sphenoid sinus, or with 
compressive symptoms related to the tumor mass [11,21]. 
Transsphenoidal microsurgery has been proven to be safe and effective, 
however, it is not devoid of complications [2,22,47]. Following excision of a 
lesions, defects created in the sella, dura, and sphenoid require 
reconstruction. If the arachnoid has been disrupted or there is significant 
suprasellar tumor extension, meticulous obliteration of the sella and 
sphenoid is necessary. Inadequate obliteration may lead to empty sella 
syndrome, graft site infection, or cerebrospinal fluid leak, which potentially 
may lead to meningitis [6,18,27,40]. Meningitis is rare, as is herniation of 
the optic nerve, optic chiasm, and /or optic track into an empty sella created 
by underpacking or migration of packing material [33]. However, CSF leak is 
not uncommon during transsphenoidal surgery, occurring in as many as 18% 
of cases [13]. 
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To prevent such complications, several options are available to repair 
the defect in the cranial base after a pituitary lesion has been removed. 
Traditionally, if the arachnoid has been tom, many steps are required to 
prevent postoperative CSF rhinorrhea. First, a piece of fascia lata (with or 
without fibrin glue) or lyophilized dura is applied to the arachnoid opening. 
Next, intradural packing material (autogenous fat or muscle, Gelfoam, or 
Surgicel) is used to obliterate the endosellar defect. This is then reinforced 
with an additional layers of abdominal fat, fascia lata, lyophilized dura, 
and/or synthetic packing. A final layer of nasal septal bone or septal cartilage 
(with or without fibrin glue) is wedged against the sella floor; placement is 
critical, as the intracranial pressure will tamponade the graft to the dura only 
if it is placed correctly [10,15,20,21,23,37,43,47]. 
Although the traditional reconstructive approaches to these skull base 
defect prevents most of the potential complications, it is still desireable to 
have a simplified technique which reduces operative time with the use of a 
synthetic, biocompatible implant material. An "ideal" implant material for 
cranial base reconstruction during transsphenoidal surgery would satisfy 
certain criteria as defined in Table 1. 
_Criteria for an Ideal Implant__ 
Immediate watertight closure of defect 
Easy to apply and contour 
Biocompatible 
Capable of osseointegration 
Volume stable or replaced by bone in a 1:1 ratio 
Resistant to Infection 
Readily available 
Allows unimpeded radiologic imaging_ 
Table 1. Criteria for an ideal implant material in sellar floor reconstruction during 
transsphenoidal surgery. 
Secondary to the high incidence of invasive adenomas complete surgical 
removal of pituitary adenomas is not always possible [41]. Postoperative 
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radiologic follow-up is required when residual tumor is suspected at surgery 
or when hormonal hypersecretion indicates a residual or recurring secretory 
adenoma. In the case of a functioning adenoma, hormone levels can be 
monitored postoperatively to detect residual tumor or recurrence. However, 
follow-up examinations may be indicated in cases of endocrinologically 
inactive adenomas. In these patients, complete resection of the adenoma can 
be documented only with radiologic follow-up [44]. For these reasons, 
materials which will not impede follow-up imaging are preferable. 
Perhaps the most important aspect in repair of defects involving the 
cranial base which communicate with the sinuses is a watertight closure, 
otherwise a potential exists for contamination of the cerebrospinal fluid. The 
goal of watertight closure presents a technical challenge in the case of complex 
three dimensional defects which are situated in the cranial base. The use 
autogenous bone or cartilage requires fibrous wound healing to occur to 
stabilize the reconstruction. Bone grafts used to reconstruct the floor of the 
sella may become dislodged or impinge on surrounding structures [13]. For 
these reasons, synthetic implants must satisfy two rather disparate 
chatacteristics: a high degree malleability, along with the capacity to quickly 
form stable, watertight barriers. 
The goals of skull base reconstruction are to provide a skeletal 
replacement that affords a stable barrier between sinus and brain. 
Biocompatibility of the implant material is important as chronic 
inflammation at the interface can lead to implant failure, with soft-tissue 
breakdown, implant mobility, and/or implant extrusion as a consequence. 
The common element in this pathophysiological process is failure to maintain 
stability and vascularization at the osseous wound interface. The mediators 
that govern the biological response at the bone-implant interface are released 
r 
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by macrophages [38]. Loosening of implants which the body considers 
"foreign", is caused by a stimulatory effect of mediators of bone resorption 
that is tenfold greater than the inhibitory effect. The more successful 
bioactive implants are capable of both osseoconduction and osseointegration, 
which promote implant stability and maintain implant volume [16,24,25]. 
Osseoconduction requires preformed channels which allow ingrowth of host 
tissues, including vascular buds and osteocyte precursors. Osseointegration 
refers to the strong, presumed chemical, bond between the implant and bone 
surface. The key is an intimate implant-bone interface that exists without an 
intervening layer of fibrous tissue. 
Of the techniques available for skull base reconstruction in 
transsphenoidal surgery, autogenous grafts are the most commonly used. 
Autogenous bone grafts taken from the naso-septum tend to resist infection 
and consequently can be left exposed to the contents of the sinuses [3]. 
However, autogenous bone, cartilage and fascial grafts may cause donor site 
morbidity, may undergo varying amounts of resorption, may be difficult to 
accurately conform to the defects, and may migrate [8,13]. Furthermore, 
nasal cartilage may not always be available in sufficient quantity. Allogenic 
bone grafts are less commonly used because they may demonstrate resorption 
rate greater than 80% [42]. Therefore, a synthetic material is advantageous 
to an autograft, as they avoid donor site morbidity, provide unlimited 
material for reconstruction, and reduce operative time by obviating the need 
for harvesting of the graft. 
Alloplasts may become encapsulated within fibrous tissue and most do 
not integrate with host tissue, resulting in significant rates implant infection 
and/or extrusion [34]. Silastic does not show a significant tissue reaction, but 
must be sold in solid form, and also exhibits memory. The property of 
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memory may account for the observation that Silastic material used to 
reconstruct the floor of the sella may become dislodged and impinge on 
surrounding structures [13]. Methylmethacrylate implants which are 
moldable intraoperatively have an exothermic polymerization phase, which is 
associated with local tissue necrosis and foreign body giant cell reaction if 
allowed to cure within sphenoid. At best this leads to tissue encapsulation 
with mild tissue response to the implant. This ex situ curing phase limits the 
applicability of standard methylmethacrylate for deep seated defects such as 
the sphenoid sinus, as effecting contour changes in the shape of a 
methylmethacrylate implant is difficult once polymerization has taken place 
[9,18]. Furthermore, methylmethacrylate implants may have a higher rate of 
infection when placed in contact with a sinus [1]. Gates, et al described the 
use of biocompatible osteoconductive polymer (BOP, a nonexothermic 
copolymer n-vinyl pyrrolidone and methylmethacrylate) in the repair of a 
resistant CSF fistula secondary to a chordoma. There was no evidence of 
rejection, infection, or recurrent CSF rhinorrhea over a period of 12 months. 
However, this powder, which is mixed into a putty intraoperatively, must be 
mixed 30-60 minutes prior to use, requires 8-10 hours before hardening in 
vivo, and does not allow for bony ingrowth as do other forms of BOP. 
Furthermore, BOP must be isolated from the CSF and from the dura [18]. 
Metals are used occasionally, usually in the form of titanium mesh. 
There is an inherent difficulty in shaping the implant in an area such as the 
sphenoid, and metals are encumbered by problems like infection and 
corrosion. Friedberg, et al recommended that if nasal cartilage is not 
available to support the packing material in the sella, that a Synthes three 
hole mini-fragment plate be used. They describe two case reports, which in 
one case it was necessary to grind the plate down the fit the defect. 
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Furthermore, the plate used was made of stainless steel, which would 
interfere with subsequent magnetic resonance imaging studies [15]. 
Other materials used in repairing the skull base defects include fibrin 
sealant, a natural coagulation product, which is may be used in conjunction 
with an autogenous graft or Gelfoam. It is adhesive to most surfaces and 
tissue compatible, however, it is biodegradable. Of note, the authors describe 
its use in 13 patients, one of which underwent repair of a CSF leak secondary 
to an erosive pituitary adenoma. The defect was repaired with a fascia and 
muscle graft coated with fibrin sealant, three weeks post-op the patient 
developed meningitis [40]. However, in another study of cerebrospinal fluid 
leaks, the dural lacerations were closed by autogenous grafts of conchal 
perichondrium with fibrin glue. After 17 months, no CSF rhinorrhea, 
meningitis, or cerebral abscess were observed postoperatively [28]. Guilty 
described another technique, a microsuture patch graft, however this 
technique may be time consuming [19]. Calcium sulfate (Plaster of Paris) has 
also been used as an implant material for in repair of skull base defects. It is 
easy to contour, however it may cause a significant inflammatory response, 
which inhibits local mediators of bone formation, and shows rapid resorption 
(within weeks to months) [30]. 
Since the mid-1970s, various preformed ceramic hydroxyapatite (HA) 
preparations have been used in an assortment of clinical applications in 
medicine and dentistry. Hydroxyapatite is the principal material of teeth and 
bone and constitutes approximately 60-70% by weight of the human skeleton. 
All forms of HA are noted for their excellent biocompatibility, ability to 
become tissue integrated, and functionally replace bone [7]. There is no 
foreign body giant cell reaction, no sustained inflammatory response, no toxic 
reaction, nor increase in serum calcium or phosphate levels [29,30,31]. The 
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soft tissue response to HA is characterized by fibro-osseous ingrowth with 
minimal inflammation and without capsule formation. Hydroxyapatite is the 
least soluble of the naturally occurring calcium phosphate salts at physiologic 
pH. This low solubility, along with its stable macromolecular structure, 
results in a relative resistance to resorption in vivo, depending on the method 
of preparation [8]. 
There are several forms of hydroxyapatite clinically available. Ceramic 
HA is sintered at high temperatures and is only available as a preformed 
hard block or as loose granules. It can be manufactured in a dense 
(nonporous) or in a porous form [31]. Another method of HA preparation is 
based upon natural coral replamineform species, in which a hard implant is 
created via a hydrothermal exchange reaction, exchanging PO4 (phosphate) for 
CO3 (carbonate) [46]. 
Solid dense hydroxyapatite is extremely stable. Porous hydroxyapatite 
can be either macroporous, microporous, or a combination of the two. If 
macropores (200-300pm) are fabricated into an HA implant, bone 
osseoconducts into the macropores, with the implant serving as a passive 
matrix for ossification. The tissue remains viable and healthy only if the 
pores are greater than 100pm diameter, which is the minimum size necessary 
for vascular ingrowth and survival in ceramic forms of hydroxyapatite 
[24,29,30]. This is in contrast to micropores, which have pores too small for 
bony ingrowth but slowly degrade [14]. The implants with both a microporous 
and macroporous structure, such as coralline HA, allow for bony ingrowth and 
slowly degrade. Despite a lack of osteoneogenesis, all forms of HA 
osseointegrate with bone by forming a direct chemical bond between the 
implant and bone interface without intervening fibrous tissue [8]. Even dense 
forms of HA show strong bonding to bone, despite the lack of pores for bony 
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ingrowth. This osseointegrative bond must therfore be chemical in nature 
[31]. 
Though blocks of ceramic hydroxyapatite can be substituted in specific 
applications for bone grafts, their use has been limited by the need to 
fabricate this material as a hard implant, which is fragile and difficult to 
sculpt. This has limited their applicability to primarily the fields of oral 
surgery and dentistry for alveolar ridge augmentation and repair of dental 
defects [14,26,35,42]. The granular form of hydroxyapatite has limitations in 
clinical application owing to a lack of structural stability and difficulty in 
containing the granules within the area requiring reconstruction. In an 
attempt to contain the granules, they may be combined with a resorbable 
medium, such as blood, collagen, fibrin glue, or calcium sulfate (Plaster of 
Paris). This is not a pure hydroxyapatite "cement", however, and after 
implantation, the carrier is resorbed and the ceramic HA granules remain as 
a permanent inclusion within a fibro-osseous matrix [42]. 
The present study involves a nonceramic form of hydroxyapatite, known 
as hydroxyapatite cement (HAC). It is produced by direct crystallization of 
hydroxyapatite in vivo, and does not require heating for the formation of a 
structurally stable implant. The major components of this cement are 
tetracalcium phosphate and dicalcium phosphate anhydrous or dicalcium 
phosphate dihydrate, which react isothermically in an aqueous environment 
(water, blood, or saline) to form a hydroxyapatite "paste" at a physiologic pH: 
Ca4(P04)20 + CaHP04 -> CasfPO^OH 
The cement sets within 15 minutes and the chemical reaction is complete 
within 4 hours, at which point it is no longer water soluble. Since HAC can be 
contoured intraoperatively, it eliminates the need for prefabrication and 
solves the contour adaptability problem faced by ceramic HA preparations. 
- 
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To date, it is the only calcium phosphate cement that both sets to a stable 
shape and converts to pure hydroxyapatite in vivo [3,7]. HAC has a 
microporous structure, with an average effective pore diameter of 2 to 5 nm. 
This pore size will allow permeation of the set cement by ionic materials and 
dyes, but prevents the passage of bacteria [8]. 
Animal studies have determined that hydroxyapatite cement has 
biocompatiblity characteristics similar to ceramic hydroxyapatite. When 
hydroxyapatite cement was used for cranioplasty in cats, there were no wound 
infections or structural failures, and specimens evaluated four years after 
cranioplasty confirm that there is no contour change in the reconstructed 
region [7]. Histologic examination of the bone-implant interface revealed a 
transient inflammatory reaction without foreign body giant cell reaction or 
fibrous encapsulation. Canine calvarial studies have shown a significant 
improvement of HAC over the results of ceramic HA implants, approximately 
half of the implant was resorbed and then replaced by bone and osteoid by 9 
months [42]. The anatomic contour was well maintained, and histology 
revealed progressive but variable replacement of the HAC by new bone and 
soft tissue without a change in the shape or volume of the reconstructed area. 
Despite the microporous structure, implant replacement of bone is presumed 
to occur through a coupling of implant resorption with osseoconduction, in a 
1:1 ratio [5,8,9,17]. 
The first clinical trials with HAC have been completed, and to date, 
there have been no toxic reactions, no increases in serum calcium level, and no 
structural failures. Most of the reconstructions have consisted of frontal bone 
contouring, frontal sinus obliteration, cranioplasty, transtemporal [32] and 
transsphenoidal defect repair. The overall infection rate was 4%, despite the 
fact that over 75% of the implants were in contact with the paranasal or 
• 
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mastoid sinuses. These clinical trials have found hydroxyapatite cement to 
be functionally nonresorbable, volume, and contour stable at more than three 
years on the basis of both computed tomography follow-up and on direct 
intraoperative inspection of those few cases which required re-operation for 
secondary reconstructive procedures [7]. 
The potential benefits of hydroxyapatite cement compared to other 
methods include: ease of application, ability to achieve watertight closure of 
the defect, replacement of the cement implant by living bone over time, 
elimination of donor site morbidity associated with autogenous grafts, and 
excellent biocompatibility compared to alloplasts. This study is based on a 
review of posttranssphenoidal computed tomography studies in 13 patients 
who had the sella floor reconstructed with hydroxyapatite cement. It was 
initiated in an attempt to determine the expected postoperative computed 
tomography appearance of HAC implants, and to help define the criteria of 
implant integrity and stability. 
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MATERIALS AND METHODS 
Patients undergoing transsphneoidal surgery were recruited. The 
protocol for reconstruction was approved by the Human Investications 
Committee and by FDA-IDE staff. Patients were excluded from the study if 
they had any of the following: (1) abnormal calcium metabolism, (2) proved 
metabolic disease, (3) recent infection (within 1 month), (4) immunologic 
abnormalities, (5) renal disease, (6) pregnancy, (7) prior radiation therapy to 
the area, or (8) age younger than 18 years. The patients ranged in age from 
21-70 years. There were 5 males and 8 females. 
The postoperative computed tomography imaging studies of 13 
consecutive patients who underwent transsphenoidal surgery with HAC 
repair of the defect in the sphenoid/sella were analyzed retrospectively. All 
patients were evaluated with either conventional radiography, computed 
tomography, and/or MRI of the operated area immediately after surgery, at 3 
months, at 6 months, at 1 year and at 2 years. The length of imaging follow¬ 
up ranged from 6 months to two years, while the clinical follow-up ranged 
from 11 to 39 months. 
The intraoperative reconstructive technique was obtained from the 
operative report. In 4 cases Gelfoam and/or Surgicel was used to fill the 
resection cavity. In 1 case autologous fat and fascia lata was used to fill the 
endosellar space. In 7 patients the sella floor defect was first covered with 
small fragments taken from either the vomerine bone, septal cartilage, or 
sphenoid cartilage, which acted as a platform for HAC administration. In 
patient 11a titanium mesh was used as a platform. In 5 patients no 
"platform" for the HAC was used (see Table 3). The sellar floor defect was 
reconstructed with hydroxyapatite cement in all patients (see Fig. 1). 
Gelfoam was used for support of the HAC in the sphenoid in 4 cases. 
' 
Fluoroscopic images were obtained prior to initiation of surgery, during 
surgery, and immediately after implantation of the hydroxyapatite cement 
(see Fig. 2). 
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Figure 1. Patient 2: Intraoperative endoscopic appearance of the hydroxyapatite cement 
implant in situ. 
(a) (b) 
Figure 2. Patient 3: Intraoperative fluoroscopic image (a) pre-implant, and (b) immediately 
post-implantation. Note the hyperdense material (arrows) overlying the sphenoid sinus, 
reconstructing the floor of the sella. 
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Hydroxyapatite cement was obtained from Paffenbarger Research 
Center of the American Dental Association Health Foundation (ADAHF) 
located at the National Institute of Standards and Technology, Gaithersburg, 
Md. 
Although magnetic resonance imaging (MRI) is regarded as the 
procedure of choice for evaluating most structures in the sellar and juxtasellar 
regions, computed tomography (CT) is superior regarding information on 
osseous anatomy. In CT, the floor of the sella is generally well demonstrated 
against the soft tissue density of the gland above and the air within the 
sphenoid sinus. On MRI the sellar floor is not well visualized because the 
signal void from the thin bone may imperceptibly merge with the gas within 
the sphenoid sinus [48]. As the primary goal of this study was in the long 
term appearance of HAC implants in sphenoid/sellar reconstruction, CT was 
the primary method used in evaluation of the implants. 
After a lateral scout view was obtained, a coronal and/or axial CT scan 
was obtained through the sinus and sellar area. Contiguous thin sections 
were obtained throughout the reconstructed area. The data was viewed using 
the bone algorithm (wide window) without contrast administration. All scans 
were obtained on a GE High Speed Advantage computed tomography scanner. 
The size of the implant was measured with calipers, using the greatest 
dimensions in the coronal, sagital, and axial plane. The postoperative studies 
were interpreted with reference to the reports of intraoperative findings and 
with surgical method. Attention was given to stability, integrity, fracture, 
migration, and implant volume. 
Patients were followed for potential complications, including: (1) 
postoperative cerebrospinal fluid rhinorrhea, (2) resorption with loss of 
. 
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implant volume and possible need for further surgery, and (3) clinically 
significant electrolyte disturbances. 
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RESULTS 
All patients have completed at least 12 months of follow-up (Table 2). 
There were no complications secondary to the surgical procedure. Patient 4 
was admitted 5 months postoperativey to rule out sphenoid sinusitis; 
endoscopic sphenoidotomy revealed no evidence of infection. 
No./Pt. Age Sex Post¬ 
op 
3 
Mo. 
6 
Mo. 
12 
Mo. 
1/WR 31 F or preg preg 
2/CW 44 M cr 
3/IL 69 F cr 
4/DS 39 M cr cr cr cr 
5/LA 70 F or cr 
6/GL 37 M or cr cr 
7/RB 62 M cr 
8/DL 21 F cr cr 
9/SG 49 F cr cr 
10/JM 21 F cr 
11/JN 42 M cr cr 
12/DW 29 F cr cr 
13/WV 35 F cr cr cr 
Table 2. Clinical summary of 13 patients with pituitary lesions and postoperative imaging 
follow-up. Note: CT: computed tomography, preg: pregnancy, blank: indicates either 
conventional radiographs or MRI. 
All patients, except for patients 4 and 9, underwent primary 
transsphenoidal surgery for histologically proven pituitary adenomas ranging 
from 7 mm to 5 cm in maximal diameter . Of the 11 patients with a primary 
pituitary adenoma, all had an endosellar location; there was suprasellar 
extension in four cases, invasion of the clivus in one case, infiltration of the 
cavernous sinus in two cases, thinning of sella floor in two cases, and erosion 
into the sphenoid in two cases (see Table 3). Six patients had prolactin 
secreting adenomas (of which two had bromocriptine therapy prior to surgical 
resection), one had a growth hormone secreting adenoma, and four had 
nonsecretory adenomas. Patient 4 underwent repair of CSF rhinorrhea from 
an initial surgery one month prior (for extirpation of a pituitary adenoma in 
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which HAC had not been used). Patient 9 underwent a second surgery for a 
recurrent non-secretory adenoma with suprasellar extension and sphenoid 
invasion in which HAC had not been originally used. 
Table 3 summarizes post-operative radiographic findings, with 
reference to the pre-operative findings and surgical technique. 
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Table 3. Summary of results: preoperative, postoperative, and follow-up radiographic 
studies with reference to pathology and surgical technique (*: materials used in addition to 
HAC)._ 
No. Preoperative 
CT/MRI 
Pathology Sellar 
Floor* 
Postoperative CT Follow-up CT 
1 erosion of sella 
with extension 
into sphenoid 
thinning of sellar 
floor 
8 
macroprolactinoma, septal 
prior bromocriptine cartilage 
treatment 
GH-adenoma 
3 thinning of sellar nonsecretory 
floor macroadenoma 
septal 
cartilage 
bone/ 
cartilage 
4 fat packing in 
spehnoid, bony 
defect in roof of 
sphenoid 
5 suprasellar 
extension 
6 suprasellar 
extension, invades 
cavernous sinus 
7 suprasellar 
CSF leak one month 
s/p initial resection 
extension 
no erosion or 
invasion 
nonsecretory 
macroadenoma 
nonsecretory 
macroadenoma 
nonsecretory 
macroadenoma 
microprolactinoma 
vomerine 
bone 
vomenne 
bone 
9 suprasellar 
extension, 
extension into 
sphenoid 
10 no erosion or 
invasion 
recurrent 
nonsecretory 
macroadenoma 
macroprolactinoma sphenoid/ 
vomerine 
11 expansion of sella, macroprolactinoma 
erosion of clivus, 
shenoid and 
caversous sinus 
invasion 
12 no erosion or microprolactinoma, 
invasion prior bromocriptine 
treatment 
bone 
fat/fascia 
packing, 
titanium 
mesh 
vomerine 
bone 
13 erosion into 
sphenoid 
macroadenoma 
layered appearance, 
superior is not in 
contact with left 
lateral edge of sellar 
floor 
layered appearance 
of HAC, unable to 
differentiate from 
septal cartilage 
(12 mos.) unable to 
differentiate bone/ 
cartilage from HAC 
HAC extending from 
roof of sphenoid into 
sella turcica 
HAC in superior 
sphenoid 
HAC in superior 
sphenoid, no layered 
appearance 
(conventional 
radiograph) 
HAC in roof of 
sphenoid, no layered 
appearance 
HAC in sphenoid, 
reconstructing the 
roof of the sella 
HAC in superior 
sphenoid, no layered 
appearance 
fat/fascia packing 
noted in endosellar 
space, titanium mesh 
and HAC extend into 
sella 
layered appearance, 
superior is not in 
contact with left 
lateral edge of sellar 
floor 
HAC reconstructs 
roof of sella 
(conventional 
radiographs showed no 
evidence of 
fragmentation or 
loosening) 
layered appearance 
persists, remodeling of 
the floor of sella 
minimal peri-implant 
soft tissue 
minimal peri-implant 
soft tissue 
HAC unchanged 
HAC unchanged 
HAC unchanged 
HAC unchanged 
HAC unchanged 
(conventional 
radiographs showed no 
evidence of migration) 
decreased amount of 
packing in sella, HAC- 
titanium unchanged 
no discontinuity of 
sellar floor noted, 
minimal peri-implant 
soft tissue 
minimal peri-implant 
soft tissue 
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Conventional radiographs were obtained in addition to computed 
tomography scans in many of the patients, from which it was possible to 
determine the stability of the implant. The appearance of the hydroxyapatite 
on conventional radiographs was of a radiopaque material overlying the area 
of the sphenoid sinus. There was no evidence of implant migration in any 
patients (see Fig. 3). 
(a) (b) 
Figure 3. Patient 1: (a) Conventional radiograph at 3 months postoperative: Note the thin 
hyperdense material overlying the area of the roof of the sphenoid sinus (arrow); there is no 
evidence of fracture, and the osseous structures are well aligned, (b) Same patient at 24 
months postoperative: Allowing for slight change in angulation, there is no evidence of 
implant migration or fracture (arrow). 
All of the immediate postoperative computed tomography images 
demonstrated soft tissue changes in the sinuses, representing blood, debris, 
and postoperative mucosal thickening. The appearance in the sphenoid sinus 
was heterogeneous, with the hyperintense hydroxyapatite cement implant, 
the soft-tissue intensity of other materials used (e.g. Gelfoam), and the other 
expected soft tissue changes as described above. HAC did not cause artifact 
streaking on computed tomography scans. On follow-up studies, the soft 
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tissue changes seen in the maxillary and ethmoids were within normal limits 
by 3 to 6 months postoperative. The high signal density representing the 
HAC remained stable throughout the follow-up period (see Figure 4). There 
was no evidence of fracture, migration, or implant instability in any patients. 
The attempt to measure the implants with calipers was abandoned when it 
was determined that slight changes in patient positioning were greatly 
interfering with the results. 
(a) (b) 
Figure 4. Patient 8. (a) Non-contrast coronal postoperative CT: Note the hyperintense HAC 
in the roof of the sphenoid, the HAC has a radiodensity similar to cortical bone, (b) At 12 
months: The HAC implant is stable without evidence of discontinuity in the roof of the 
sphenoid. Also note the marked decrease in soft tissue density in the sphenoid sinus. 
Differences in scanning technique likely account for the relative decrease in density at the 
implant-bone interface. 
Of the seven patients which had autologous bone and/or cartilage in 
addition to the HAC, three demonstrated a "layered" appearance. In two of 
these patients (patients 1 and 12), the lateral edge of the superior layer was 
discontinuous with the floor of the sella, and was of a decreased radiodensity 
compared to the more inferior layers. In the third implant which appeared 
layered (patient 4), there were no appreciable differences in density amongst 
the layers (see Figure 5). 
- 
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(c) 
Figure 5. Patient 2: Non-contrast coronal scans (a) immediately postoperative, (b) at 1 
month, and (c) at 2 years postoperative. Note the layered appearance of the hyperintense 
hydroxyapatite cement in the sphenoid sinus. The soft tissue changes noted in the sphenoid 
sinus in the postoperative and one month follow-up scans have resolved in the 2 year 
postoperative scan. The appearance of the HAC does not change with time, and there is no 
evidence of implant loosening or migration. 
There was minimal peri-implant soft tissue in four patients. One of 
these patients had a microprolactinoma and was reconstructed with 
autogenous bone, one patient had a nonsecretory macroadenoma and was 
reconstructed with additional autogenous bone, another had a nonsecretory 
macroadenoma and only HAC, and the final patient had the HAC implanted 
during surgery for CSF leak (see Figure 6). 
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(a) (b) 
(c) 
Figure 6. Patient 4: (a) Non-contrast coronal preoperative CT: Note the previous evidence 
of prior transsphenoidal resection: there is air suprasellar cistern, and along right lateral 
fissure, (b) Immediate postoperative CT: Note the hyperintense appearance of the HAC 
implant in the sphenoid sinus (arrows), (c) CT at 24 months postoperative: Note the 
stability of the HAC and the integreity of the roof of the sphenoid There is increased soft 
tissue density in the sphenoid sinus (arrows), with less than 2% change in implant-bone 
interface. 
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DISCUSSION 
The interpretation of post-operative images of the sella turcica region 
may be difficult because the postoperative appearance of the site of excision 
depends on numerous factors, including the size and invasiveness of the 
adenoma prior to surgery, the surgical approach, the type and quantity of 
implanted materials, and the time course of resorption of these materials 
[44]. Non-contrast high-resolution computed tomography with coronal slices 
has been described to be the best method for visualizing bony detail of the 
sella and parasellar region [12,36]. 
In this study, the immediate postoperative computed tomography 
scans of all patients demonstrated soft tissue changes in the maxillary, 
ethmoid, and sphenoid sinuses, which were expected from the surgery itself. 
Soft tissue density was presumed secondary to debris, blood, mucoperiosteal 
thickening, or synthetic packing material (i.e. Gelfoam). These changes 
resolved 3 to 6 months postoperatively, which is comparable to other studies 
[13,17]. In addition, the sphenoid exhibited a heterogeneous appearance 
secondary to the hyperdense HAC implant, along with the aforementioned 
soft tissue changes. 
The initial computed tomography appearance of the hydroxyapatite 
cement greatly depended on the surgical technique utilized. The significance 
of the "layered" appearance seen in three of patients illustrates this point. 
All three patients were reconstructed with HAC using a "platform" of septal 
cartilage or bone obtained during exposure of the sphenoid and sella. In two 
patients, a superior layer was evident with a radiodensity similar to the 
adjacent cortical bone of the roof of the spehnoid, which was less hyperintense 
than the more inferior layers. It was thought that the more superior layer 
represented the autologous graft material, while the more inferior portion 
• r.i £:i>‘ 
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represented the hydroxyapatite cement. This was further supported by the 
observation that in both cases the superior edge was initially oriented 
superiorly compared with the medial edge of the defect in the sellar floor; on 
follow-up studies, this superior layer could no longer be visualized. This 
observation is more consistent with the superior layer as the autogenous 
graft, as autogenous graft tends to remodel and/or resorb more rapidly in 
comparison to hydroxyapatite implants [29,30], In the third case, all of the 
"layers" were all of similar radiodensity, and did not change throughout the 
follow-up period (see Figure 4). In this example, the layered appearance is 
more likely a result of the method of HAC application, as repeating layers 
was necessary in many of the larger implants. In addition, not all cases in 
which autogenous bone had been used in addition to HAC demonstrated a 
layered appearance. There were four cases where no layered appearance was 
visualized. Therefore, it may be difficult to differentiate between the two 
materials with postoperative CT scanning, implying an intimate apposition 
of the two materials. 
Minimal peri-implant soft tissue noted in four patients, the 
significance of which is not known at this time. No correlation between 
preoperative or surgical technique could be determined. Two patients had 
non-secretory macroadenomas, one had a microprolactinoma, and one had a 
persistent cerebrospinal fluid leak (see Figure 6). Two patients were 
reconstructed with additional autogenous bone, and two were not. There was 
no correlation between the amount of HAC implanted and the development of 
soft tissue density at the interface. The significance of these peri-implant 
soft-tissue findings is difficult to assess. The interpretation was hampered 
by the inconsistent window settings used during scanning, and by the lack of 
use of a head frame for consistent patient positioning. Allowing for these 
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limitations, it was determined that the change in implant-interface 
characteristics was less than 2% over a two year period. This finding, along 
with the lack of change in implant-interface characteristics in the other 9 
patients and the lack of implant migration or fracture as evidenced by CT, 
leads to the interpretation that HAC forms a stable implant with respect to 
shape and volume over 24 months radiographically, and over 39 months 
clinically. 
With the numerous methods available for sellar floor reconstruction 
available, it is important to be able to differentiate the radiographic 
appearance of implanted material from residual or recurrent tumor (the 
incidence of recurrent pituitary adenomas may be as high as 12% [2,45]). 
This is especially true for non-functioning adenomas where radiographic 
evaluation may be the only method available to determine residual or 
recurrent tumor, where it is important to be able to differentiate the residual 
tumor from the packing material. Various materials have been used to pack 
the sphenoid sinus during transsphenoidal surgery to achieve hemostasis or 
prevent leakage of CSF, most of which may appear as endosellar masses on 
MRI [44]. In addition to the ease in handling and structural benefits of HAC 
compared to other implant materials, it is also less likely to interfere with 
subsequent MRI follow-up for tumor recurrence. Hydroxyapatite has an MRI 
signal intensity similar to cortical bone (as opposed to the soft tissue 
intensity of most other implant materials), and it is therefore less likely to 
interfere with determination of residual or recurrent tumor. However, 
recurrence generally occurs from 4 to 10 years after surgery [2,45]. As the 
follow-up of this study has not yet reached this time range, it remains to be 
determined if this implant will interfere with subsequent diagnosis and/or 
treatment of this procedure. 
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In prior postoperative computed tomography studies of patients after 
transsphenoidal surgery, bony defects of the sellar floor, and "disappearance" 
of the packing material on follow-up studies has been described [45]. The 
implication of these observations is the potential for post-surgical 
complications, the most common being cerebrospinal fluid leak. This is not a 
minor consideration, as the incidence of postoperative cerebrospinal fluid leak 
has been reported to be as high as 9.6% [40]. Furthermore, CSF rhinorrhea 
has been implicated as the most frequent cause of post-surgical meningitis 
after transsphenoidal surgery. The main risks of postoperative CSF 
rhinorrhea is inadequate repair of an arachnoid tear. However, even with an 
adequate closure, it is possible for the cartilage or bone graft traditionally 
used to become dislodged witha sustained valsalva maneuvers. The cause of 
the leak may be traced back to a break in the integrity of the arachnoid and 
sellar floor. Many cases of CSF leak will respond to conservative 
management, such as continous lumbar drainage or serial lumbar punctures. 
If there is persistent CSF leak, however, re-operation may be necessary [40]. 
It is therfore desireable to achieve an initial watertight seal, thus preventing 
additional morbidity secondary to CSF rhinorrhea. 
In addition to watertight closure, implant stability, material 
biocompatibility, and ease in placement into the surgical site are also 
important considerations in sellar floor reconstruction. Prior to the advent of 
hydroxyapatite cement, there was not a universally accepted ideal implant 
material. The traditional method of meticulous technique using a 
combination of materials has been used with varying success to reconstruct 
the defect created during transsphenoidal surgery to prevent CSF leak, the 
advantages and disadvantages of which are summarized in Table 4. 
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Table 4. Advantages and disadvantages of grafts and implants for sphenoid sinus/sellar 
floor reconstruction (adapted from 1161)._ 
Technique Advantages Disadvantages 
Autologous bone/cartilage graft Patient's own graft 
Inductive potential 
Success high 
Limits on amount 
Donor site morbidity 
Potential for volume loss 
Difficult to contour 
Migration possible 
Soft tissue grafts Patient's own graft 
Success high 
May be used in conjunction 
with fibrin sealant 
Donor site morbidity 
Potential for volume loss 
Possibility of infection ! 
Allograft Readily available 
Inductive potential 
Processing issues 
Possibility of infection 
Volume loss 
Difficult to contour 
Migration possible 
Alloplastic Readily available 
Volume/shape stable 
Possibility of infection 
Biocompatibility issues 
May exhibit memory 
Difficult to contour 
Migration possible 
Metal 
Biomaterials 
Readily available 
Volume/shape stable 
Prone to infection/corrosion 
Difficult to contour 
Potentially interferes with 
subsequent radiologic studies 
Calcium sulfate Readily available 
Easy to contour 
Rapid resorption with minimal 
deposition of bone 
Significant inflammatory response 
HAC Excellent biocompatibility 
Volume/shape stable 
Easy to contour 
Resistant to infection 
Specialized surgical technique 
Minimum host bone requirements 
[1,3,5,7,8,9,11,13,15,16,17,18,20,23,28,34,40,42] 
HAC is a unique preparation which can be molded intraoperatively and 
sets in vivo within four hours to a watertight pure hydroxyapatite implant. 
Histologically, HAC has been shown to have biocompatibility similar to other 
forms of prefabricated, commercial HA [7]. Furthermore, the lack of fibrous 
encapsulation and foreign body giant cell formation compare favorably with 
what is seen with alloplastic implants such as methylmethacrylate or 
Silastic. The osseoconductive and resorptive properties of this cement 
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suggest that it has the potential to function as a successful implant when in 
direct contact with viable bone, whereby it is replaced, at least in part, with 
osseous tissue, without a significant loss of volume [9]. This is a unique 
property compared to the commercial ceramic HA preparations presently 
available [8]. 
Potential limitations in the use of HAC include the observation that for 
a successful reconstruction, HAC must be used as a dense paste and placed 
into a relatively dry operative field, and must be in contact with living bone at 
the time of implantation to initiate the process of osteoid deposition [42]. 
This potentially limits its use to situations in which pre- or postoperative 
radiation therapy would not be utilized [40]. 
After more than two years of follow-up, HAC has demonstrated 
stability and integrity as a method of sellar floor reconstruction. Although it 
is occasionally used in combination with other grafts successfully in certain 
situations, this technique limits the total dependence on fascia lata, fat, 
muscle, tissue adhesives, and surgical and cartilage packs. In addition to the 
immediate watertight closure seen with HAC, it is also simplifies the 
reconstructive procedure, and decreases operative time. It is therefore 
postulated that hydroxyapatite cement may be superior to the methods of 
skull base reconstruction presently available. 
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